Genomic analyses identify molecular subtypes of pancreatic cancer

Nature

Volumn 531, Issue 7592, 2016, Pages 47-52

  Bailey, Peter ^a,b   Chang, David K ^b,c,d,e,ak   Nones, Katia ^a,f   Johns, Amber L ^c,ak   Patch, Ann Marie ^a,f   Gingras, Marie Claude ^g   Miller, David K ^a,c,ak   Christ, Angelika N ^a   Bruxner, Tim J C ^a   Quinn, Michael C ^a,f   Nourse, Craig ^a,b   Murtaugh, L Charles ^h   Harliwong, Ivon ^a   Idrisoglu, Senel ^a   Manning, Suzanne ^a   Nourbakhsh, Ehsan ^a   Wani, Shivangi ^a,f   Fink, Lynn ^a   Holmes, Oliver ^a,f   Chin, Venessa ^c,ak   Anderson, Matthew J ^a   Kazakoff, Stephen ^a,f   Leonard, Conrad ^a,f   Newell, Felicity ^a   Waddell, Nick ^a   Wood, Scott ^a,f   Xu, Qinying ^a,f   Wilson, Peter J ^a   Cloonan, Nicole ^a,f   Kassahn, Karin S ^a,i,j   Taylor, Darrin ^a   Quek, Kelly ^a   Robertson, Alan ^a   Pantano, Lorena ^k   Mincarelli, Laura ^b   Sanchez, Luis N ^b   Evers, Lisa ^b   Wu, Jianmin ^c,ak   Pinese, Mark ^c,ak   Cowley, Mark J ^c,ak   Jones, Marc D ^b,c,ak   Colvin, Emily K ^c,ak   Nagrial, Adnan M ^c,ak   Humphrey, Emily S ^c,ak   Chantrill, Lorraine A ^c,l,ak   Mawson, Amanda ^c,ak   Humphris, Jeremy ^c,ak   Chou, Angela ^c,m,ak   Pajic, Marina ^c,e,ak   Scarlett, Christopher J ^c,n,ak   Pinho, Andreia V ^c,ak   Giry Laterriere, Marc ^c,ak   Rooman, Ilse ^c,ak   Samra, Jaswinder S ^o,p   Kench, James G ^c,p,q,ak   Lovell, Jessica A ^c,ak   Merrett, Neil D ^e,r   Toon, Christopher W ^c,ak   Epari, Krishna ^s   Nguyen, Nam Q ^t   Barbour, Andrew ^u   Zeps, Nikolajs ^v,al   Moran Jones, Kim ^b   Jamieson, Nigel B ^b,w,x   Graham, Janet S ^b,y   Duthie, Fraser ^z   Oien, Karin ^c,z,ak   Hair, Jane ^z   Grützmann, Robert ^aa,aj   Maitra, Anirban ^ab   Iacobuzio Donahue, Christine A ^ac   Wolfgang, Christopher L ^ad   Morgan, Richard A ^ad   Lawlor, Rita T ^ae,af   Corbo, Vincenzo ^ae   Bassi, Claudio ^ae   Rusev, Borislav ^ae   Capelli, Paola ^af   Salvia, Roberto ^ae   Tortora, Giampaolo ^ae   Mukhopadhyay, Debabrata ^ag   Petersen, Gloria M ^ag   Munzy, Donna M ^g   Fisher, William E ^g   Karim, Saadia A ^ah   Eshleman, James R ^ad   Hruban, Ralph H ^ad   Pilarsky, Christian ^aa   Morton, Jennifer P ^ah   Sansom, Owen J ^w,ah   Scarpa, Aldo ^ae,af   Musgrove, Elizabeth A ^b   Bailey, Ulla Maja Hagbo ^b   Hofmann, Oliver ^b,k   Sutherland, Robert L ^c,ak   Wheeler, David A ^g   Gill, Anthony J ^c,p,ak   Gibbs, Richard A ^g   Pearson, John V ^a,f   Waddell, Nicola ^a,f   Biankin, Andrew V ^b,c,d,e,x,ak   Grimmond, Sean M ^a,b,ai   more..

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d BANKSTOWN LIDCOMBE HOSPITAL   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^g BAYLOR COLLEGE OF MEDICINE   (United States)

^h UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

ⁱ SA PATHOLOGY   (Australia)

^j UNIVERSITY OF ADELAIDE   (Australia)

^k HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^l CAMPBELLTOWN HOSPITAL   (Australia)

^m ST VINCENT S HOSPITAL   (Australia)

ⁿ UNIVERSITY OF NEWCASTLE   (Australia)

^o ROYAL NORTH SHORE HOSPITAL   (Australia)

^p UNIVERSITY OF SYDNEY   (Australia)

^q ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^r UNIVERSITY OF WESTERN SYDNEY   (Australia)

^s FIONA STANLEY HOSPITAL   (Australia)

^t ROYAL ADELAIDE HOSPITAL   (Australia)

^u PRINCESS ALEXANDRA HOSPITAL   (Australia)

^v UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^w UNIVERSITY OF GLASGOW   (United Kingdom)

^x GLASGOW ROYAL INFIRMARY   (United Kingdom)

^y BEATSON WEST OF SCOTLAND CANCER CENTRE   (United Kingdom)

^z SOUTHERN GENERAL HOSPITAL   (United Kingdom)

^aa DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^ab UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^ac MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^ad JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^ae UNIVERSITY AND HOSPITAL TRUST OF VERONA   (Italy)

^af UNIVERSITY OF VERONA   (Italy)

^ag MAYO CLINIC   (United States)

^ah BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^ai UNIVERSITY OF MELBOURNE   (Australia)

^aj UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^ak GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^al ST JOHN OF GOD HOSPITAL   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRG1 PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; HEPATOCYTE NUCLEAR FACTOR 1BETA; HEPATOCYTE NUCLEAR FACTOR 3BETA; HEPATOCYTE NUCLEAR FACTOR 3GAMMA; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; K RAS PROTEIN; LIVER RECEPTOR HOMOLOG 1; MNX1 PROTEIN; MUCIN 1; MUCIN 5AC; NEUROGENIC DIFFERENTIATION FACTOR; NOTCH RECEPTOR; PROTEIN; PROTEIN P53; PROTEIN SWI; RBPJL PROTEIN; ROUNDABOUT RECEPTOR; SLIT PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; TRANSCRIPTION FACTOR GATA 6; TRANSCRIPTION FACTOR NKX2.2; TRANSCRIPTION FACTOR PDX 1; TRANSCRIPTION FACTOR SNF; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; WNT PROTEIN; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; CELL RECEPTOR; DNA BINDING PROTEIN; FOXA2 PROTEIN, HUMAN; FOXA3 PROTEIN, HUMAN; HISTONE DEMETHYLASE; HOMEODOMAIN PROTEIN; MNX1 PROTEIN, HUMAN; NEUROD1 PROTEIN, HUMAN; NKX-2.2 HOMEDOMAIN PROTEIN; NR5A2 PROTEIN, HUMAN; NUCLEAR PROTEIN; PANCREATIC AND DUODENAL HOMEOBOX 1 PROTEIN; RBPJL PROTEIN, HUMAN; TP53 PROTEIN, HUMAN; TP63 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTOME; TUMOR SUPPRESSOR PROTEIN; UTX PROTEIN, HUMAN;

CANCER; DIFFERENTIATION; DNA; EVOLUTION; GENE EXPRESSION; GENETIC ANALYSIS; IMMUNE SYSTEM; PATERNAL EFFECT; RNA; TUMOR;

ACINAR CELL CARCINOMA; ADENOSQUAMOUS CARCINOMA; ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; AUTOPHAGY; CHROMATIN; CONTROLLED STUDY; DNA REPAIR; GENE DOSAGE; GENOMICS; GLYCOSYLATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MOLECULAR EVOLUTION; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA PROCESSING; RNA SEQUENCE; SQUAMOUS CELL CARCINOMA; TRANSCRIPTOMICS; TUMOR MICROENVIRONMENT; UPREGULATION; ANIMAL; CLASSIFICATION; DNA METHYLATION; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETIC TRANSCRIPTION; GENETICS; HUMAN GENOME; IMMUNOLOGY; METABOLISM; MUTATION; PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOLOGY; PROGNOSIS; SURVIVAL; TUMOR CELL LINE; TUMOR GENE;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; DNA METHYLATION; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; GENES, NEOPLASM; GENOME, HUMAN; GENOMICS; HEPATOCYTE NUCLEAR FACTOR 3-BETA; HEPATOCYTE NUCLEAR FACTOR 3-GAMMA; HISTONE DEMETHYLASES; HOMEODOMAIN PROTEINS; HUMANS; MICE; MUTATION; NUCLEAR PROTEINS; PANCREATIC NEOPLASMS; PROGNOSIS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SURVIVAL ANALYSIS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSCRIPTOME; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 84960194345     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature16965     Document Type: Article

References (50)

1. Rahib, L. et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 74, 2913–2921 (2014).
2. Waddell, N. et al. Whole genomes redefine the mutational landscape of pancreatic cancer. Nature 518, 495–501 (2015).
3. Jones, S. et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321, 1801–1806 (2008).
4. Wang, L. et al. Whole-exome sequencing of human pancreatic cancers and characterization of genomic instability caused by MLH1 haploinsufficiency and complete deficiency. Genome Res. 22, 208–219 (2012).
5. Biankin, A. V. et al. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature 491, 399–405 (2012).
6. Alexandrov, L. B., Nik-Zainal, S., Wedge, D. C., Campbell, P. J. & Stratton, M. R. Deciphering signatures of mutational processes operative in human cancer. Cell Rep. 3, 246–259 (2013).
7. Nones, K. et al. Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling. Int. J. Cancer 135, 1110–1118 (2014).
8. Nones, K. et al. Genomic catastrophes frequently arise in esophageal adenocarcinoma and drive tumorigenesis. Nature Commun. 5, 5224 (2014).
9. Patch, A. M. et al. Whole-genome characterization of chemoresistant ovarian cancer. Nature 521, 489–494 (2015).
10. The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature 511, 543–550 (2014).
11. Bechara, E. G., Sebestyen, E., Bernardis, I., Eyras, E. & Valcarcel, J. RBM5, 6, and 10 differentially regulate NUMB alternative splicing to control cancer cell proliferation. Mol. Cell 52, 720–733 (2013).
12. Scott, L. M. & Rebel, V. I. Acquired mutations that affect pre-mRNA splicing in hematologic malignancies and solid tumors. J. Natl. Cancer Inst. 105, 1540–1549 (2013).
13. Maguire, S. L. et al. SF3B1 mutations constitute a novel therapeutic target in breast cancer. J. Pathol. 235, 571–580 (2015).
14. Horn, S. et al. Mind bomb 1 is required for pancreatic β-cell formation. Proc. Natl Acad. Sci. USA 109, 7356–7361 (2012).
15. + breast cancer patients. Proc. Natl Acad. Sci. USA 108, 3761–3766 (2011).
16. Shain, A. H., Salari, K., Giacomini, C. P. & Pollack, J. R. Integrative genomic and functional profiling of the pancreatic cancer genome. BMC Genomics 14, 624 (2013).
17. Tubio, J. M. et al. Mobile DNA in cancer. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes. Science 345, 1251343 (2014).
18. Hoadley, K. A. et al. Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell 158, 929–944 (2014).
19. Brody, J. R. et al. Adenosquamous carcinoma of the pancreas harbors KRAS2, DPC4 and TP53 molecular alterations similar to pancreatic ductal adenocarcinoma. Mod. Pathol. 22, 651–659 (2009).
20. Engelmann, D. & Putzer, B. M. Emerging from the shade of p53 mutants: N-terminally truncated variants of the p53 family in EMT signaling and cancer progression. Sci. Signal. 7, re9 (2014).
21. Hale, M. A. et al. The homeodomain protein PDX1 is required at mid-pancreatic development for the formation of the exocrine pancreas. Dev. Biol. 286, 225–237 (2005).
22. von Figura, G., Morris, J. P. IV, Wright, C. V. & Hebrok, M. Nr5a2 maintains acinar cell differentiation and constrains oncogenic Kras-mediated pancreatic neoplastic initiation. Gut 63, 656–664 (2014).
23. Hale, M. A. et al. The nuclear hormone receptor family member NR5A2 controls aspects of multipotent progenitor cell formation and acinar differentiation during pancreatic organogenesis. Development 141, 3123–3133 (2014).
24. Rooney, M. S., Shukla, S. A., Wu, C. J., Getz, G. & Hacohen, N. Molecular and genetic properties of tumors associated with local immune cytolytic activity. Cell 160, 48–61 (2015).
25. Weissmueller, S. et al. Mutant p53 drives pancreatic cancer metastasis through cell-autonomous PDGF receptor β signaling. Cell 157, 382–394 (2014).
26. Miller, B. W. et al. Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy. EMBO Mol. Med. 7, 1063–1076 (2015).
27. Collisson, E. A. et al. Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy. Nature Med. 17, 500–503 (2011).
28. Moffitt, R. A. et al. Virtual microdissection identifies distinct tumor-and stroma-specific subtypes of pancreatic ductal adenocarcinoma. Nature Genet. 47, 1168–1178 (2015).
29. Cerami, E. et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2, 401–404 (2012).
30. Lawrence, M. S. et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499, 214–218 (2013).
31. Gonzalez-Perez, A. et al. IntOGen-mutations identifies cancer drivers across tumor types. Nature Methods 10, 1081–1082 (2013).
32. Leiserson, M. D. et al. Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes. Nature Genet. 47, 106–114 (2015).
33. Razick, S., Magklaras, G. & Donaldson, I. M. iRefIndex: a consolidated protein interaction database with provenance. BMC Bioinformatics 9, 405 (2008).
34. Li, B. & Dewey, C. N. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics 12, 323 (2011).
35. Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139–140 (2010).
36. Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).
37. Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923–930 (2014).
38. Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
39. Leek, J. T., Johnson, W. E., Parker, H. S., Jaffe, A. E. & Storey, J. D. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics 28, 882–883 (2012).
40. Kuehn, H., Liberzon, A., Reich, M. & Mesirov, J. P. Using GenePattern for gene expression analysis. Current Protoc. Bioinformatics Chapter 7, Unit 7 12, (2008).
41. Wilkerson, M. D. & Hayes, D. N. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics 26, 1572–1573 (2010).
42. Law, C. W., Chen, Y., Shi, W. & Smyth, G. K. voom: Precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 15, R29 (2014).
43. Hänzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics 14, 7 (2013).
44. Langfelder, P. & Horvath, S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 9, 559 (2008).
45. Langfelder, P., Zhang, B. & Horvath, S. Defining clusters from a hierarchical cluster tree: the Dynamic Tree Cut package for R. Bioinformatics 24, 719–720 (2008).
46. Fang, H. & Gough, J. The ‘dnet’ approach promotes emerging research on cancer patient survival. Genome Med. 6, 64 (2014).
47. Wu, G. & Stein, L. A network module-based method for identifying cancer prognostic signatures. Genome Biol. 13, R112 (2012).
48. Du, P., Kibbe, W. A. & Lin, S. M. lumi: a pipeline for processing Illumina microarray. Bioinformatics 24, 1547–1548 (2008).
49. Tan, E. H. et al. Functions of TAp63 and p53 in restraining the development of metastatic cancer. Oncogene 25, 3325–3333 (2014).
50. Yoshihara, K. et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nature Commun. 4, 2612 (2013).